Samadi N - Search Results

1

Chaperone-Assisted Soluble Expression of a Humanized Anti-EGFR ScFv Antibody in E. Coli.

Veisi K, Farajnia S, Zarghami N, Khoram Khorshid HR, Samadi N, Ahdi Khosroshahi S, Zarei Jaliani H. Veisi K, et al. Among authors: samadi n. Adv Pharm Bull. 2015 Dec;5(Suppl 1):621-7. doi: 10.15171/apb.2015.084. Epub 2015 Dec 31. Adv Pharm Bull. 2015. PMID: 26793607 Free PMC article.

2

Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles.

Shafiei-Irannejad V, Samadi N, Salehi R, Yousefi B, Rahimi M, Akbarzadeh A, Zarghami N. Shafiei-Irannejad V, et al. Among authors: samadi n. Pharm Res. 2018 Apr 18;35(6):119. doi: 10.1007/s11095-018-2404-7. Pharm Res. 2018. PMID: 29671072

3

Peroxisome Proliferator-Activated Receptor Ligands and Their Role in Chronic Myeloid Leukemia: Therapeutic Strategies.

Yousefi B, Samadi N, Baradaran B, Shafiei-Irannejad V, Zarghami N. Yousefi B, et al. Among authors: samadi n. Chem Biol Drug Des. 2016 Jul;88(1):17-25. doi: 10.1111/cbdd.12737. Epub 2016 Mar 6. Chem Biol Drug Des. 2016. PMID: 26841308 Review.

4

Metformin enhances doxorubicin sensitivity via inhibition of doxorubicin efflux in P-gp-overexpressing MCF-7 cells.

Shafiei-Irannejad V, Samadi N, Yousefi B, Salehi R, Velaei K, Zarghami N. Shafiei-Irannejad V, et al. Among authors: samadi n. Chem Biol Drug Des. 2018 Jan;91(1):269-276. doi: 10.1111/cbdd.13078. Epub 2017 Aug 24. Chem Biol Drug Des. 2018. PMID: 28782285

5

Engineering of Ocriplasmin Variants by Bioinformatics Methods for the Reduction of Proteolytic and Autolytic Activities.

Baghban R, Farajnia S, Ghasemi Y, Mortazavi M, Ghasemali S, Zakariazadeh M, Zarghami N, Samadi N. Baghban R, et al. Among authors: samadi n. Iran J Med Sci. 2021 Nov;46(6):454-467. doi: 10.30476/ijms.2020.86984.1705. Iran J Med Sci. 2021. PMID: 34840386 Free PMC article.

6

New insights into antidiabetic drugs: Possible applications in cancer treatment.

Shafiei-Irannejad V, Samadi N, Salehi R, Yousefi B, Zarghami N. Shafiei-Irannejad V, et al. Among authors: samadi n. Chem Biol Drug Des. 2017 Dec;90(6):1056-1066. doi: 10.1111/cbdd.13013. Epub 2017 Jul 23. Chem Biol Drug Des. 2017. PMID: 28456998 Review.

7

Balaglitazone reverses P-glycoprotein-mediated multidrug resistance via upregulation of PTEN in a PPARγ-dependent manner in leukemia cells.

Yousefi B, Azimi A, Majidinia M, Shafiei-Irannejad V, Badalzadeh R, Baradaran B, Zarghami N, Samadi N. Yousefi B, et al. Among authors: samadi n. Tumour Biol. 2017 Oct;39(10):1010428317716501. doi: 10.1177/1010428317716501. Tumour Biol. 2017. PMID: 28978268 Free article.

8

Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge.

Yousefi B, Zarghami N, Samadi N, Majidinia M. Yousefi B, et al. Among authors: samadi n. Anticancer Agents Med Chem. 2016;16(12):1541-1548. doi: 10.2174/1871520616666160204112941. Anticancer Agents Med Chem. 2016. PMID: 26845135 Review.

9

Doxorubicin Changes Bax /Bcl-xL Ratio, Caspase-8 and 9 in Breast Cancer Cells.

Sharifi S, Barar J, Hejazi MS, Samadi N. Sharifi S, et al. Among authors: samadi n. Adv Pharm Bull. 2015 Sep;5(3):351-9. doi: 10.15171/apb.2015.049. Epub 2015 Sep 19. Adv Pharm Bull. 2015. PMID: 26504757 Free PMC article.

10

Combination therapy increases the efficacy of docetaxel, vinblastine and tamoxifen in cancer cells.

Samadi N, Ghanbari P, Mohseni M, Tabasinezhad M, Sharifi S, Nazemieh H, Rashidi MR. Samadi N, et al. J Cancer Res Ther. 2014 Jul-Sep;10(3):715-21. doi: 10.4103/0973-1482.139152. J Cancer Res Ther. 2014. PMID: 25313766 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters